SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jonathan I. Epstein, Michael J. Zelefsky, Daniel D. Sjoberg, Joel B. Nelson, Lars Egevad, Cristina Magi-Galluzzi, Andrew J. Vickers, Anil V. Parwani, Victor E. Reuter, Samson W. Fine, James A. Eastham, Peter Wiklund, Misop Han, Chandana A. Reddy, Jay P. Ciezki, Tommy Nyberg, Eric A. Klein, A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score, European Urology, 2016, 69, 3, 428

    CrossRef

  2. 2
    Nicolas Mottet, Noel Clarke, Maria De Santis, Filiberto Zattoni, Juan Morote, Steven Joniau, Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?, BJU International, 2015, 115, 3
  3. 3
    Atiqullah Aziz, Carsten Kempkensteffen, Matthias May, Steffen Lebentrau, Maximilian Burger, Felix K-H Chun, Sabine Brookman-May, Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer, Expert Review of Anticancer Therapy, 2015, 15, 6, 649

    CrossRef

  4. 4
    Chad G. Rusthoven, Julie A. Carlson, Timothy V. Waxweiler, Norman Yeh, David Raben, Thomas W. Flaig, Brian D. Kavanagh, The prognostic significance of Gleason scores in metastatic prostate cancer, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 5, 707

    CrossRef

  5. 5
    Ahmed El-Shater Bosaily, Manit Arya, Hashim Ahmed, Clinical predictors of survival in men with castration-resistant prostate cancer, Cancer, 2013, 119, 22
  6. 6
    Julia H. Hayes, Mari Nakabayashi, Philip W. Kantoff, Reply to clinical predictors of survival in men with castration-resistant prostate cancer, Cancer, 2013, 119, 22